Towards deracemization in the absence of grinding through crystal transformation, ripening, and racemization

Christos Xiouras, Emma Van Cleemput, Andries Kumpen, Joop H. Ter Horst, Tom Van Gerven, Georgios D. Stefanidis

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

New insights into the obscure mechanisms of solid-state deracemization phenomena are obtained by crystal ripening experiments that, contrary to standard techniques, exclude attrition enhancement (grinding). The results point out that small particles and an initial size imbalance between the two enantiomeric crystal populations can intensify the rate of solidstate enantiomeric enrichment even in the absence of intermediate actions (e.g., grinding or thermal cycling). On this ground, a new process that creates such initial conditions is designed and exemplified for the proteinogenic glutamic acid. As a first step, racemic compound solvate (DL-glutamic acid monohydrate) crystals are completely converted to small-sized conglomerate anhydrate crystals, in the presence of larger seeds of a single chirality. After the transformation is complete and the racemization catalyst is added, the suspension contains an equal number of small-sized conglomerate crystals of both enantiomers together with the larger seeds of the preferred enantiomer. Over time, the large crystals of the preferred enantiomer tend to grow at the expense of smaller ones, which dissolve. This, combined with the fast racemization, leads to enantiomeric enrichment. The possible occurrence of enantioselective agglomeration between small and seed crystals speeds up this process by removing small crystals of the preferred enantiomer. Since most amino acids and several other pharmaceutical compounds are known to form metastable racemic hydrate crystals, it is expected that this new method is readily applicable to a variety of compounds. In addition, the process provides a technically simpler and more scalable route to enantiomeric enrichment compared to attritionenhanced deracemization, and its applicability extends to the wider pool of compounds that crystallize as racemic crystals.

LanguageEnglish
Pages882-890
Number of pages9
JournalCrystal Growth and Design
Volume17
Issue number2
Early online date15 Dec 2016
DOIs
Publication statusPublished - 1 Feb 2017

Fingerprint

grinding
Crystals
Enantiomers
crystals
enantiomers
seeds
glutamic acid
Seed
Glutamic Acid
comminution
Acids
Chirality
Thermal cycling
agglomeration
Hydrates
chirality
hydrates
Drug products
amino acids
Amino acids

Keywords

  • solution-mediated transformation
  • racemic
  • solvate crystals
  • conglomerates
  • solid-state deracemization
  • isothermal ripening
  • enantiomeric enrichment

Cite this

Xiouras, Christos ; Van Cleemput, Emma ; Kumpen, Andries ; Ter Horst, Joop H. ; Van Gerven, Tom ; Stefanidis, Georgios D. / Towards deracemization in the absence of grinding through crystal transformation, ripening, and racemization. In: Crystal Growth and Design . 2017 ; Vol. 17, No. 2. pp. 882-890.
@article{204a2f7aa6a24144bfbe3c32bb620b70,
title = "Towards deracemization in the absence of grinding through crystal transformation, ripening, and racemization",
abstract = "New insights into the obscure mechanisms of solid-state deracemization phenomena are obtained by crystal ripening experiments that, contrary to standard techniques, exclude attrition enhancement (grinding). The results point out that small particles and an initial size imbalance between the two enantiomeric crystal populations can intensify the rate of solidstate enantiomeric enrichment even in the absence of intermediate actions (e.g., grinding or thermal cycling). On this ground, a new process that creates such initial conditions is designed and exemplified for the proteinogenic glutamic acid. As a first step, racemic compound solvate (DL-glutamic acid monohydrate) crystals are completely converted to small-sized conglomerate anhydrate crystals, in the presence of larger seeds of a single chirality. After the transformation is complete and the racemization catalyst is added, the suspension contains an equal number of small-sized conglomerate crystals of both enantiomers together with the larger seeds of the preferred enantiomer. Over time, the large crystals of the preferred enantiomer tend to grow at the expense of smaller ones, which dissolve. This, combined with the fast racemization, leads to enantiomeric enrichment. The possible occurrence of enantioselective agglomeration between small and seed crystals speeds up this process by removing small crystals of the preferred enantiomer. Since most amino acids and several other pharmaceutical compounds are known to form metastable racemic hydrate crystals, it is expected that this new method is readily applicable to a variety of compounds. In addition, the process provides a technically simpler and more scalable route to enantiomeric enrichment compared to attritionenhanced deracemization, and its applicability extends to the wider pool of compounds that crystallize as racemic crystals.",
keywords = "solution-mediated transformation, racemic, solvate crystals, conglomerates, solid-state deracemization, isothermal ripening, enantiomeric enrichment",
author = "Christos Xiouras and {Van Cleemput}, Emma and Andries Kumpen and {Ter Horst}, {Joop H.} and {Van Gerven}, Tom and Stefanidis, {Georgios D.}",
note = "“This document is the Accepted Manuscript version of a Published Work that appeared in final form in Crystal Growth and Design, copyright {\circledC} American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see http://dx.doi.org/10.1021/acs.cgd.6b01758",
year = "2017",
month = "2",
day = "1",
doi = "10.1021/acs.cgd.6b01758",
language = "English",
volume = "17",
pages = "882--890",
journal = "Crystal Growth and Design",
issn = "1528-7483",
publisher = "American Chemical Society",
number = "2",

}

Towards deracemization in the absence of grinding through crystal transformation, ripening, and racemization. / Xiouras, Christos; Van Cleemput, Emma; Kumpen, Andries; Ter Horst, Joop H.; Van Gerven, Tom; Stefanidis, Georgios D.

In: Crystal Growth and Design , Vol. 17, No. 2, 01.02.2017, p. 882-890.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Towards deracemization in the absence of grinding through crystal transformation, ripening, and racemization

AU - Xiouras, Christos

AU - Van Cleemput, Emma

AU - Kumpen, Andries

AU - Ter Horst, Joop H.

AU - Van Gerven, Tom

AU - Stefanidis, Georgios D.

N1 - “This document is the Accepted Manuscript version of a Published Work that appeared in final form in Crystal Growth and Design, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see http://dx.doi.org/10.1021/acs.cgd.6b01758

PY - 2017/2/1

Y1 - 2017/2/1

N2 - New insights into the obscure mechanisms of solid-state deracemization phenomena are obtained by crystal ripening experiments that, contrary to standard techniques, exclude attrition enhancement (grinding). The results point out that small particles and an initial size imbalance between the two enantiomeric crystal populations can intensify the rate of solidstate enantiomeric enrichment even in the absence of intermediate actions (e.g., grinding or thermal cycling). On this ground, a new process that creates such initial conditions is designed and exemplified for the proteinogenic glutamic acid. As a first step, racemic compound solvate (DL-glutamic acid monohydrate) crystals are completely converted to small-sized conglomerate anhydrate crystals, in the presence of larger seeds of a single chirality. After the transformation is complete and the racemization catalyst is added, the suspension contains an equal number of small-sized conglomerate crystals of both enantiomers together with the larger seeds of the preferred enantiomer. Over time, the large crystals of the preferred enantiomer tend to grow at the expense of smaller ones, which dissolve. This, combined with the fast racemization, leads to enantiomeric enrichment. The possible occurrence of enantioselective agglomeration between small and seed crystals speeds up this process by removing small crystals of the preferred enantiomer. Since most amino acids and several other pharmaceutical compounds are known to form metastable racemic hydrate crystals, it is expected that this new method is readily applicable to a variety of compounds. In addition, the process provides a technically simpler and more scalable route to enantiomeric enrichment compared to attritionenhanced deracemization, and its applicability extends to the wider pool of compounds that crystallize as racemic crystals.

AB - New insights into the obscure mechanisms of solid-state deracemization phenomena are obtained by crystal ripening experiments that, contrary to standard techniques, exclude attrition enhancement (grinding). The results point out that small particles and an initial size imbalance between the two enantiomeric crystal populations can intensify the rate of solidstate enantiomeric enrichment even in the absence of intermediate actions (e.g., grinding or thermal cycling). On this ground, a new process that creates such initial conditions is designed and exemplified for the proteinogenic glutamic acid. As a first step, racemic compound solvate (DL-glutamic acid monohydrate) crystals are completely converted to small-sized conglomerate anhydrate crystals, in the presence of larger seeds of a single chirality. After the transformation is complete and the racemization catalyst is added, the suspension contains an equal number of small-sized conglomerate crystals of both enantiomers together with the larger seeds of the preferred enantiomer. Over time, the large crystals of the preferred enantiomer tend to grow at the expense of smaller ones, which dissolve. This, combined with the fast racemization, leads to enantiomeric enrichment. The possible occurrence of enantioselective agglomeration between small and seed crystals speeds up this process by removing small crystals of the preferred enantiomer. Since most amino acids and several other pharmaceutical compounds are known to form metastable racemic hydrate crystals, it is expected that this new method is readily applicable to a variety of compounds. In addition, the process provides a technically simpler and more scalable route to enantiomeric enrichment compared to attritionenhanced deracemization, and its applicability extends to the wider pool of compounds that crystallize as racemic crystals.

KW - solution-mediated transformation

KW - racemic

KW - solvate crystals

KW - conglomerates

KW - solid-state deracemization

KW - isothermal ripening

KW - enantiomeric enrichment

UR - http://www.scopus.com/inward/record.url?scp=85011344647&partnerID=8YFLogxK

UR - http://pubs.acs.org/journal/cgdefu

U2 - 10.1021/acs.cgd.6b01758

DO - 10.1021/acs.cgd.6b01758

M3 - Article

VL - 17

SP - 882

EP - 890

JO - Crystal Growth and Design

T2 - Crystal Growth and Design

JF - Crystal Growth and Design

SN - 1528-7483

IS - 2

ER -